Well CIBA has gone directly from "exceptional results" to being unworkable. That takes out most of the surface treatment related products.
It makes me wonder what is the outlook for other product areas, particularly those with scant reporting. Areas including dental trials, air conditioning, bone cement, theraputics, and the more recently silenced Commercial Microbiology.
What is Bosignal's likelyhood of success. My hope is largely with the MIC oil and gas product. Based on earlier announcements I expected conclusive lab results by now. Should ConocoPhillips be seen as a step further than Commercial Micobiology? Is their testing a pro-forma simply for independant verification and trial-production, or could their testing blow MIC out of the water?
Biosignal is fast running out of money, and perhaps goodwill.
I would really like a comprehensive investor update right now, and have asked the company when that might be available.
- Forums
- ASX - By Stock
- BOS
- whats the outlook
whats the outlook
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online